JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 10 May 2004. doi:10.1083/jcb.200308011
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 165, Number 3, 371-381
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2273K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Subauste, M. C.
Right arrow Articles by Hahn, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Subauste, M. C.
Right arrow Articles by Hahn, K. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Vinculin modulation of paxillin–FAK interactions regulates ERK to control survival and motility



M. Cecilia Subauste1, Olivier Pertz1, Eileen D. Adamson2, Christopher E. Turner3, Sachiko Junger1, and Klaus M. Hahn1

1 Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037
2 The Burnham Institute, La Jolla Cancer Research Center, La Jolla, CA 92037
3 Department of Cell and Developmental Biology, State University of New York, Upstate Medical University, Syracuse, NY 13210

Address correspondence to K.M. Hahn at his present address Dept. of Pharmacology, Mary Ellen Jones Bldg., Rm. 1141, CB 7365, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365. Tel.: (919) 966-1307. email: khahn{at}med.unc.edu

Cells lacking vinculin are highly metastatic and motile. The reasons for this finding have remained unclear. Both enhanced survival and motility are critical to metastasis. Here, we show that vinculin null (vin–/–) cells and cells expressing a vinculin Y822F mutant have increased survival due to up-regulated activity of extracellular signal–regulated kinase (ERK). This increase is shown to result from vinculin's modulation of paxillin–FAK interactions. A vinculin fragment (amino acids 811–1066) containing the paxillin binding site restored apoptosis and suppressed ERK activity in vin–/– cells. Both vinY822F and vin–/– cells exhibit increased interaction between paxillin and focal adhesion kinase (FAK) and increased paxillin and FAK phosphorylation. Transfection with paxillin Y31FY118F dominant-negative mutant in these cells inhibits ERK activation and restores apoptosis. The enhanced motility of vin–/– and vinY822F cells is also shown to be due to a similar mechanism. Thus, vinculin regulates survival and motility via ERK by controlling the accessibility of paxillin for FAK interaction.

Key Words: apoptosis; extracellular signal–regulated kinase; anoikis; MAPK; migration


Abbreviations used in this paper: {Delta} talin bs, deleted talin binding sites; Ab, antibody; DEVD-AMC, N-acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin; ERK, extracellular signal–regulated kinase; FAT, focal adhesion targeting; FRNK, FAK-related nonkinase; MEK, MAPK kinase; mRFP, monomeric red fluorescent protein; PI-3K, phosphatidylinositol-3 kinase.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Sensing detachment
William A. Wells
J. Cell Biol. 2004 165: 295. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents